Cargando…
Preeclampsia and Related Cardiovascular Risk: Common Genetic Background
PURPOSE OF REVIEW: Preeclampsia (PE) is a hypertensive disorder exclusive for pregnancy. It affects women all over the world and poses a great threat to life, both for mother and child. No definitive treatment exists and placenta delivery comprises the only known cure for PE. One of the most severe...
Autores principales: | Lisowska, Michalina, Pietrucha, Tadeusz, Sakowicz, Agata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6028827/ https://www.ncbi.nlm.nih.gov/pubmed/29971632 http://dx.doi.org/10.1007/s11906-018-0869-8 |
Ejemplares similares
-
Preeclampsia and COVID-19: the Role of Inflammasome Activation
por: Cornelius, Denise C., et al.
Publicado: (2022) -
Placental Disease and the Maternal Syndrome of Preeclampsia: Missing Links?
por: Tannetta, Dionne, et al.
Publicado: (2013) -
The Clinical Value of Rodent Models in Understanding Preeclampsia Development and Progression
por: Ramdin, Sapna, et al.
Publicado: (2023) -
Elucidating the Pathogenesis of Pre-eclampsia Using In Vitro Models of Spiral Uterine Artery Remodelling
por: McNally, Ross, et al.
Publicado: (2017) -
Pre-eclampsia: the Potential of GSNO Reductase Inhibitors
por: Everett, Thomas R., et al.
Publicado: (2017)